Literature DB >> 8927048

The chemistry of peroxovanadium compounds relevant to insulin mimesis.

A Shaver1, J B Ng, D A Hall, B I Posner.   

Abstract

The inorganic coordination chemistry of peroxovanadium compounds relevant to insulin mimesis is reviewed. The structure and kinetic reactivity of solutions of vanadate anion, vanadyl complexes and peroxovanadate complexes are briefly compared. Peroxovanadium compounds contain an oxo group, one or two peroxo ligands (O2(2-)) and an ancillary ligand which is usually bidentate. These compounds approximate a trigonal bipyramidal structure which can be divided conceptually into a polar 'oxo' half and a relatively non-polar organic half. This presents a number of interesting design variations which are discussed with respect to the development of a rudimentary structure-activity correlation of insulin mimetic ability.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8927048     DOI: 10.1007/bf01075913

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Bis(maltolato)oxovanadium(IV) is a potent insulin mimic.

Authors:  J H McNeill; V G Yuen; H R Hoveyda; C Orvig
Journal:  J Med Chem       Date:  1992-04-17       Impact factor: 7.446

2.  The bromoperoxidase from the lichen Xanthoria parietina is a novel vanadium enzyme.

Authors:  H Plat; B E Krenn; R Wever
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Effects of vanadium on glucose metabolism in vitro.

Authors:  E L Tolman; E Barris; M Burns; A Pansini; R Partridge
Journal:  Life Sci       Date:  1979-09-24       Impact factor: 5.037

4.  The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor.

Authors:  G R Dubyak; A Kleinzeller
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

5.  Oral vanadyl sulfate in treatment of diabetes mellitus in rats.

Authors:  S Ramanadham; J J Mongold; R W Brownsey; G H Cros; J H McNeill
Journal:  Am J Physiol       Date:  1989-09

6.  Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.

Authors:  B I Posner; R Faure; J W Burgess; A P Bevan; D Lachance; G Zhang-Sun; I G Fantus; J B Ng; D A Hall; B S Lum
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

7.  Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase.

Authors:  S Kadota; I G Fantus; G Deragon; H J Guyda; B Hersh; B I Posner
Journal:  Biochem Biophys Res Commun       Date:  1987-08-31       Impact factor: 3.575

8.  Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium.

Authors:  C Djordjevic; G L Wampler
Journal:  J Inorg Biochem       Date:  1985-09       Impact factor: 4.155

9.  Crystal structure of human protein tyrosine phosphatase 1B.

Authors:  D Barford; A J Flint; N K Tonks
Journal:  Science       Date:  1994-03-11       Impact factor: 47.728

10.  Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.

Authors:  C E Heyliger; A G Tahiliani; J H McNeill
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

View more
  7 in total

1.  Redox modulation of basal and beta-adrenergically stimulated cardiac L-type Ca(2+) channel activity by phenylarsine oxide.

Authors:  Carl Sims; Robert D Harvey
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

Review 2.  Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.

Authors:  Sunil K Panchal; Stephen Wanyonyi; Lindsay Brown
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

Review 3.  Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.

Authors:  I G Fantus; E Tsiani
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 4.  Positive and negative selection during B lymphocyte development.

Authors:  John G Monroe; Gregory Bannish; Ezequiel M Fuentes-Panana; Leslie B King; Peter C Sandel; James Chung; Richard Sater
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  New oxo-bridged peroxotungsten complexes containing biogenic co-ligand as potent inhibitors of alkaline phosphatase activity.

Authors:  Pankaj Hazarika; Diganta Kalita; Swapnalee Sarmah; Nashreen S Islam
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

6.  Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis.

Authors:  G Bannish; E M Fuentes-Pananá; J C Cambier; W S Pear; J G Monroe
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

7.  Oxidative stress changes observed in selected organs of African giant rats (Cricetomys gambianus) exposed to sodium metavanadate.

Authors:  Ifukibot L Usende; James O Olopade; Benjamin O Emikpe; Ademola A Oyagbemi; Adeolu A Adedapo
Journal:  Int J Vet Sci Med       Date:  2018-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.